Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Genmab A (GMAB) EBIAT (2024 - 2025)

Historic EBIAT for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to -$932.0 million.

  • Genmab A's EBIAT fell 26884.04% to -$932.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $963.0, marking a year-over-year decrease of 9999.99%. This contributed to the annual value of $963.0 for FY2025, which is 9999.99% down from last year.
  • According to the latest figures from Q4 2025, Genmab A's EBIAT is -$932.0 million, which was down 26884.04% from $401.0 million recorded in Q3 2025.
  • Genmab A's EBIAT's 5-year high stood at $552.0 million during Q4 2024, with a 5-year trough of -$932.0 million in Q4 2025.